1-Methoxy-4-cadinene

Details

Top
Internal ID da076399-78f5-48c1-b0ea-57cb42bd17bd
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (1R,4S,4aR,8aR)-8a-methoxy-1,6-dimethyl-4-propan-2-yl-2,3,4,4a,7,8-hexahydro-1H-naphthalene
SMILES (Canonical) CC1CCC(C2C1(CCC(=C2)C)OC)C(C)C
SMILES (Isomeric) C[C@@H]1CC[C@H]([C@H]2[C@]1(CCC(=C2)C)OC)C(C)C
InChI InChI=1S/C16H28O/c1-11(2)14-7-6-13(4)16(17-5)9-8-12(3)10-15(14)16/h10-11,13-15H,6-9H2,1-5H3/t13-,14+,15+,16-/m1/s1
InChI Key WPYWXKMNACRLCE-FXUDXRNXSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C16H28O
Molecular Weight 236.39 g/mol
Exact Mass 236.214015512 g/mol
Topological Polar Surface Area (TPSA) 9.20 Ų
XlogP 4.20
Atomic LogP (AlogP) 4.43
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 2

Synonyms

Top
(1R,4S,4aR,8aR)-8a-methoxy-1,6-dimethyl-4-propan-2-yl-2,3,4,4a,7,8-hexahydro-1H-naphthalene

2D Structure

Top
2D Structure of 1-Methoxy-4-cadinene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9969 99.69%
Caco-2 + 0.9382 93.82%
Blood Brain Barrier + 0.6750 67.50%
Human oral bioavailability + 0.5571 55.71%
Subcellular localzation Mitochondria 0.5285 52.85%
OATP2B1 inhibitior - 0.8535 85.35%
OATP1B1 inhibitior + 0.9240 92.40%
OATP1B3 inhibitior + 0.9410 94.10%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.9096 90.96%
P-glycoprotein inhibitior - 0.9054 90.54%
P-glycoprotein substrate - 0.8023 80.23%
CYP3A4 substrate + 0.5272 52.72%
CYP2C9 substrate - 0.5963 59.63%
CYP2D6 substrate - 0.6830 68.30%
CYP3A4 inhibition - 0.7145 71.45%
CYP2C9 inhibition - 0.8333 83.33%
CYP2C19 inhibition - 0.5261 52.61%
CYP2D6 inhibition - 0.9493 94.93%
CYP1A2 inhibition - 0.8294 82.94%
CYP2C8 inhibition - 0.8590 85.90%
CYP inhibitory promiscuity - 0.7459 74.59%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8463 84.63%
Carcinogenicity (trinary) Non-required 0.5238 52.38%
Eye corrosion - 0.9782 97.82%
Eye irritation - 0.6389 63.89%
Skin irritation + 0.5000 50.00%
Skin corrosion - 0.9800 98.00%
Ames mutagenesis - 0.6991 69.91%
Human Ether-a-go-go-Related Gene inhibition - 0.3718 37.18%
Micronuclear - 0.8800 88.00%
Hepatotoxicity + 0.5094 50.94%
skin sensitisation + 0.6729 67.29%
Respiratory toxicity - 0.6444 64.44%
Reproductive toxicity + 0.7111 71.11%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity - 0.6770 67.70%
Acute Oral Toxicity (c) III 0.7772 77.72%
Estrogen receptor binding - 0.6517 65.17%
Androgen receptor binding - 0.5367 53.67%
Thyroid receptor binding - 0.5603 56.03%
Glucocorticoid receptor binding - 0.5428 54.28%
Aromatase binding - 0.7412 74.12%
PPAR gamma - 0.7552 75.52%
Honey bee toxicity - 0.7214 72.14%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity + 0.6800 68.00%
Fish aquatic toxicity + 0.9832 98.32%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.51% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 90.77% 97.25%
CHEMBL4072 P07858 Cathepsin B 90.55% 93.67%
CHEMBL1871 P10275 Androgen Receptor 87.53% 96.43%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 87.33% 91.11%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 85.77% 94.80%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.85% 95.89%
CHEMBL2581 P07339 Cathepsin D 84.08% 98.95%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 83.54% 86.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.27% 95.56%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 81.53% 97.14%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 80.14% 94.45%
CHEMBL1994 P08235 Mineralocorticoid receptor 80.03% 100.00%

Cross-Links

Top
PubChem 11447728
NPASS NPC26540
LOTUS LTS0228361
wikiData Q104399649